Kamran Alam
CHIEF FINANCIAL OFFICER · Taysha Gene Therapies, Inc.
- 2025
- Feb 6, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kamran Alam files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sukumar Nagendran - $5.33M in TSHA purchases and sales in the last 12 months
- Sean P. Nolan - $840K in TSHA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kamran Alam?
Kamran Alam is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Taysha Gene Therapies, Inc. (TSHA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kamran Alam last file a Form 4?
The most recent primary Form 4 on record is dated 6 February 2026, one of 4 filings going back to 2025.
Has Kamran Alam been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($648K) across all tracked filings.
